Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer
NCT05949983
Summary
Adapted physical activity (APA) was recognized as a non-drug therapy by the French Health Authority (HAS) in 2011. Very few studies have examined the efficiency of APA programs during the active phase of treatment in cancer patients. The investigators assumed that non-drug therapy such as APA could improve the quality of life and reduces health costs. The main objective of this study is to assess the efficiency of a standardized APA program, as compared to conventional management including simple recommendations for the practice of physical activity in women in phase active breast cancer treatment.
Eligibility
Inclusion Criteria: * women with breast cancer * any type of breast cancer, all grades, all stages * during treatment: surgery +/- chemotherapy +/- radiotherapy +/- hormone therapy Exclusion Criteria: * World Health Organization (WHO) 4 * Unstable angina * Uncontrolled Atrial fibrillation * Uncontrolled high blood pressure * Recent myocardial infarction or myocarditis or pericarditis or thromboembolic disease (less than 3 weeks) * Aortic stenosis or valve disease to operate * Cardiac or respiratory failure, with dyspnea at rest * Symptomatic anemia, thrombocytopenia * Lytic or painful bone metastases, Severe osteoporosis * Severe infectious syndrome, * Surgery in the last 3 weeks * Extreme fatigue, sharp pain, dizziness, disturbance of consciousness, severe undernutrition * Contraindication to the practice of an adapted physical activity programme * Currently involved or exclusion period of a interventional study or adapted Physical Activity program * Patient with protective measures (guardianship, curators, and deprivation of liberty). * Pregnancy or breastfeeding * Patient with severe functional limitations
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05949983